One of the oldest and largest US pharmaceutical companies – Bristol-Myers Squibb – has expanded its Israel operation in order to get help from Israeli specialists with their launch of a new drug for the treatment of melanoma. http://www.globes.co.il/serveen/globes/docview.asp?did=1000710584&fid=1725

Weizmann Institute scientists have uncovered the method that white blood cells use to target invading pathogens. The fascinating process almost resembles army-training techniques. http://wis-wander.weizmann.ac.il/hide-and-seek-signals

Israel’s Collplant has signed an agreement with Pfizer to jointly develop an orthopaedic product for the repair of compound fractures. Collplant manufactures human collagen from plants. http://www.globes.co.il/serveen/globes/docview.asp?did=1000709584&fid=1725 http://www.youtube.com/watch?v=6W8UVanYyLM

Israel’s AtoxBio Ltd. has raised $3.5 million to finance a Phase II clinical trial for the effectiveness of its drug AB 103 for necrotizing soft tissue infections (NSTI). The drug has been granted fast-track orphan status by the US Food … Continue reading →

Please read this latest report about the wonderful work of Israeli humanitarian organisation “Save A Child’s Heart”. At a time of political stalemate between Israel and the Palestinian Authority, hearts are still being fixed and bonds are being forged between … Continue reading →

The “Innovations in Cardiovascular Interventions” (ICI) conference that took place in Tel Aviv was one of the largest international conferences in the field of cardiovascular intervention. Israel is a leader in cardiology innovation, producing stents, heart valves inserted by catheters, … Continue reading →